BRAVELLE
BRAVELLE
Discontinued
DIN Number
02268140
Drug Class
Human
Market Date
Jun 15, 2005
Company
HC
Ferring Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02268140
AIG Number0115014001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
G03GA04 UROFOLLITROPIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
,
Subcutaneous
AHFS Classification68:18.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
UROFOLLITROPINActive
Strength: 75 UNIT / VIAL
Monograph: UROFOLLITROPIN